Phenytoin as an augmentation for SSRI failures: A small controlled study

Journal of Affective Disorders

Volumn 96, Issue 1-2, 2006, Pages 123-126

  Shapira, B ^a   Nemets, B ^b   Trachtenberg, A ^b   Belmaker, R H ^b  

^a HERZOG HOSPITAL   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

Lithium augmentation; Phenytoin; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; FLUVOXAMINE; LITHIUM; PAROXETINE; PHENYTOIN; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRANQUILIZER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; MALE; MOOD DISORDER; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT FAILURE;

ADULT; AGED; ANTICONVULSANTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PERSONALITY INVENTORY; PHENYTOIN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 33749639033     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.05.011     Document Type: Article

References (19)

1. Barbee J.G., and Jamhour N.J. Lamotrigine as an augmentation agent in treatment-resistant depression. J. Clin. Psychiatry 63 8 (2002) 737-741
2. Barbosa L., Berk M., and Vorster M. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J. Clin. Psychiatry 64 4 (2003) 403-407
3. Bauer M., Bschor T., Kunz D., Berghofer A., Strohle A., and Muller-Oerlinghausen B. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am. J. Psychiatry 157 9 (2000) 1429-1435
4. Bauer M., Forsthoff A., Baethge C., Adli M., Berghofer A., Dopfmer S., and Bschor T. Lithium augmentation therapy in refractory depression-update 2002. Eur. Arch. Psychiatry Clin. Neurosci. 253 3 (2003) 132-139
5. Bschor T., Canata B., Muller-Oerlinghausen B., and Bauer M. Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression. J. Affect. Disord. 64 2-3 (2001) 261-265
6. Cipriani A., Pretty H., Hawton K., and Geddes J.R. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am. J. Psychiatry 162 10 (2005) 1805-1819
7. Davis L.L., Kabel D., Patel D., Choate A.D., Foslien-Nash C., Gurguis G.N., Kramer G.L., and Petty F. Valproate as an antidepressant in major depressive disorder. Psychopharmacol. Bull. 32 4 (1996) 647-652
8. Fava M., Rosenbaum J.F., McGrath P.J., Stewart J.W., Amsterdam J.D., and Quitkin F.M. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am. J. Psychiatry 151 9 (1994) 1372-1374
9. Heninger G.R., Charney D.S., and Sternberg D.E. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression. Arch. Gen. Psychiatry 40 12 (1983) 1335-1342
10. Mishory A., Yaroslavsky Y., Bersudsky Y., and Belmaker R.H. Phenytoin as an antimanic anticonvulsant: a controlled study. Am. J. Psychiatry 157 3 (2000) 463-465
11. Mishory A., Winokur M., and Bersudsky Y. Prophylactic effect of phenytoin in bipolar disorder: a controlled study. Bipolar Disord. 5 6 (2003) 464-467
12. Nemets B., Mishory A., Levine J., and Belmaker R.H. Inositol addition does not improve depression in SSRI treatment failures. J. Neural Transm. 106 7-8 (1999) 795-798
13. Nemets B., Fux M., Levine J., and Belmaker R.H. Combination of antidepressant drugs: the case of inositol. Hum. Psychopharmacol. 16 1 (2001) 37-43
14. Nemets B., Bersudsky Y., and Belmaker R.H. Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder. J. Clin. Psychiatry 66 5 (2005) 586-590
15. Nierenberg, A.A., Fava, M., Trivedi, M.H., Wisniewski, R., Thase, M.E., McGrath, P.J., Alpert, J.E., Warden, D., J.F., L., Niederehe, G., Lebowitz, B., Shores-Wilson, K., Rush, A.J., in press. A comparison of lithium and thyroid augmentation following two failed medication treatments for depression: a STAR*D Report. Am. J. Psychiatry.
16. Normann C., Hummel B., Scharer L.O., Horn M., Grunze H., and Walden J. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. J. Clin. Psychiatry 63 4 (2002) 337-344
17. Otani K., Yasui N., Kaneko S., Ohkubo T., Osanai T., and Sugawara K. Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression. Int. Clin. Psychopharmacol. 11 1 (1996) 55-57
18. Post R.M., and Uhde T.W. Carbamazepine as a treatment for refractory depressive illness and rapidly cycling manic-depressive illness. In: Zohar J., and Belmaker R.H. (Eds). Treating Resistant Depression (1987), PMA Publishing Corp
19. Steinacher L., Vandel P., Zullino D.F., Eap C.B., Brawand-Amey M., and Baumann P. Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study. Eur. Neuropsychopharmacol. 12 3 (2002) 255-260